Could a diabetes drug curb cannabis cravings?

NCT ID NCT07523633

First seen Apr 21, 2026 · Last updated May 13, 2026 · Updated 3 times

Summary

This study tests if semaglutide, a medicine used for diabetes and weight loss, can help adults with cannabis use disorder reduce their cannabis use. About 100 people who want to cut down or stop using cannabis will get either semaglutide or a placebo for 20 weeks. The main goal is to see if semaglutide leads to less cannabis use compared to the placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.